Bli medlem
Bli medlem

Du är här


Getinge Group: Further developed and focused strategy, and preparation for distribution of Patient & Post-Acute Care to shareholders of Getinge

Press ReleaseGothenburg, October 18, 2016

Getinge Group has recently performed a strategic review to clarify its
long-term strategy for ensuring sustainable and profitable growth.
Getinge will focus on two business areas, Acute Care Therapies and
Surgical Workflows. In light of this, the Board of Directors intends
to propose to an Extraordinary General Meeting a distribution of
Patient & Post-Acute Care, formerly Extended Care, to Getinge's

Over the last few months, Getinge has performed a company-wide
strategic review to clarify the most optimal long-term strategy for
the company and to ensure sustainable and profitable growth that
captures growth opportunities for all business areas.

As a result, Getinge has decided to focus on two business areas, Acute
Care Therapies and Surgical Workflows. The Acute Care Therapies
offering includes solutions for cardiac, pulmonary and vascular
therapies and a broad selection of products and therapies for
intensive care. Surgical Workflows develops products and solutions
for infection control, equipment for surgical workplaces and advanced
IT systems for hospitals.

Based on this long-term strategic direction, the Board of Directors
has tasked the management of Getinge Group to prepare for a
distribution and listing of Patient & Post-Acute Care, formerly
Extended Care, in accordance with Lex ASEA*. The proposal is subject
to a decision by the shareholders at an Extraordinary General Meeting
(EGM) during the fall 2017. Should the EGM approve the Board's
proposal, the aim is to complete the listing not later than during
the first quarter of 2018.

"The future listing of Patient & Post-Acute Care will increase the
ability of both companies to realize their strategies and to best
continue to enhance customer benefits and shareholder value," says
Joacim Lindoff, Acting President & CEO of Getinge Group.

Patient & Post-Acute Care's offering encompasses products and
solutions for safe patient handling, prevention of venous
thromboembolisms, medical beds, hygiene systems and early mobility,
among others.

Following a split, both companies will have a more concentrated focus,
with more opportunities to continue to develop products and solutions
to meet customer needs and thereby help solve healthcare challenges.

The financial targets for both companies will be determined and
presented as part of the preparation work.

This announcement will be further addressed in the scheduled
conference call today, October 18, at 3.00 PM CET, hosted by Joacim
Lindoff, Acting President & CEO and Reinhard Mayer, CFO.

To join the conference, please call:

Swedish dial in number: +46 (0)8 5065 3942
UK dial in number: +44 (0)20 7026 5967
US dial in number: +1 719-325-2202
Participant passcode: 5615835

During the telephone conference a presentation will be held. To access
the presentation, please use this link:

* Lex ASEA means, in brief, that a parent company can, under certain
circumstances, distribute the company's shares in a subsidiary to its
shareholders without any immediate Swedish taxation arising on the
distribution for the shareholders.

For further information, please contact:
Joacim Lindoff Kornelia Rasmussen
Acting President & CEO Executive Vice President Group Communications
Tel: +46 (0)10 335 32 10 Tel: +46 (0)10 335 58 10
E-mail: E-mail:

Getinge Group is a leading global provider of innovative solutions for
operating rooms, intensive-care units, hospital wards, sterilization
departments, elderly care and for life science companies and
institutions. Getinge's unique customer offering mirrors the
hospital's organization and value chain, and the solutions are used
before, during and after the patients' hospital stay. Based on
first-hand experience and close partnerships, Getinge provides
innovative healthcare solutions that improve every-day life for
people, today and tomorrow.

This information is information that Getinge AB is obliged to make
public pursuant to the EU Market Abuse Regulation. The information
was submitted for publication, through the agency of the contact
person set out above, at 12:59 p.m. CET on

October 18, 2016.

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.